GPT and metabolic dysfunction-associated steatotic liver disease: Laboratory investigations revealed that only ALT (serum glutamic-pyruvic transaminase (SGPT)) and serum triglyceride levels showed a statistically significant difference between NAFLD cases and controls (p<0.05), while all other parameters showed no significant variation (Table 2).